Sonic Fund News Today : Breaking News, Live Updates & Top Stories | Vimarsana

In this article, we will take a look at the top 10 stock picks of Lawrence Kam's Sonic Capital.

More from AP

Adverum Files Investor Presentation Highlighting Significant Strategic Progress and Purpose-Built Board to Oversee Stockholder Value Creation Urges Stockholders to Vote the WHITE Proxy Card “FOR” ALL of Adverum’s Three Highly Qualified, Diverse and Independent Directors: Dawn Svoronos, Reed V. Tuckson, M.D. and Thomas Woiwode, Ph.D. REDWOOD CITY, Calif., April 22, 2021 (GLOBE NEWSWIRE) — Adverum Biotechnologies, Inc. (Nasdaq: ADVM), a clinical-stage gene therapy company targeting unmet medical needs in ocular and rare diseases, today announced that it has filed a new investor present...

Share this article Share this article HONOLULU, April 8, 2021 /PRNewswire/ -- The Sonic Fund II, L.P. ("Sonic"), which beneficially owns approximately 6.7% of the outstanding common stock of Adverum Biotechnologies, Inc. (NASDAQ: ADVM) (the "Company" or "Adverum"), announced today that it has filed a preliminary proxy statement and GREEN proxy card with the SEC in conjunction with the Company's 2021 annual meeting of shareholders (the "2021 Annual Meeting"), which is expected to take place sometime in mid-May to early June.  In addition, due to the short interest in Adverum's stock, Sonic p...

Adverum Announces Board Slate for 2021 Annual Meeting and Reiterates Commitment to Stockholder Value Creation Equity Performance: from Sonic Fund letter to Adverum Equity Performance: from Sonic Fund letter to Adverum Image 1: from Sonic Fund letter to Adverum Image 1: from Sonic Fund letter to Adverum Image 2: from Sonic Fund letter to Adverum Image 2: from Sonic Fund letter to Adverum Image 3: from Sonic Fund letter to Adverum Image 3: from Sonic Fund letter to Adverum Image 4: from Sonic Fund letter to Adverum Image 4: from Sonic Fund letter to Adverum Image 5: from Sonic Fund letter to Ad...